These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24617622)

  • 1. Is TOF normalization suitable on daily clinical practice? In reply.
    Pompei L; Della Rocca G
    Acta Anaesthesiol Scand; 2014 Apr; 58(4):497-9. PubMed ID: 24617622
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery times after sugammadex: is the data flawed?
    Kopman AF
    Acta Anaesthesiol Scand; 2014 Apr; 58(4):496-7. PubMed ID: 24400790
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
    Kopman AF; Kopman DJ; Ng J; Zank LM
    J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex in a parturient with myotonic dystrophy.
    Stourac P; Krikava I; Seidlova J; Strazevska E; Huser M; Hruban L; Janku P; Gal R
    Br J Anaesth; 2013 Apr; 110(4):657-8. PubMed ID: 23508494
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis].
    Monsalve Naharro JA; Gerónimo Pardo M; Ortiz Sánchez VE; Pérez Valdivieso JM
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):624-5. PubMed ID: 22263413
    [No Abstract]   [Full Text] [Related]  

  • 7. In response.
    Kotake Y; Suzuki T; Ozaki M; Takeda J
    Anesth Analg; 2014 Mar; 118(3):690. PubMed ID: 24557115
    [No Abstract]   [Full Text] [Related]  

  • 8. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In reply.
    Pongrácz A; Nemes R; Fülesdi B; Tassonyi E
    Anesthesiology; 2014 Feb; 120(2):508-9. PubMed ID: 24448083
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of Sugammadex for Neuromuscular Reversal in Cardiac Transplant Patients.
    Varela N; Golvano M; Pérez-Pevida B
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):e37. PubMed ID: 27222050
    [No Abstract]   [Full Text] [Related]  

  • 11. Reasoning of an anomaly: residual block after sugammadex.
    Naguib M; Brull SJ; Arkes HR
    Anesth Analg; 2013 Aug; 117(2):297-300. PubMed ID: 23881373
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal rocuronium sensitivity after titrated intraoperative sugammadex.
    McLoughlin PD
    Anaesth Intensive Care; 2012 Mar; 40(2):352. PubMed ID: 22417037
    [No Abstract]   [Full Text] [Related]  

  • 13. In Reply.
    Meyer MJ; Sasaki N; Eikermann M
    Anesthesiology; 2015 Jul; 123(1):233-4. PubMed ID: 26510199
    [No Abstract]   [Full Text] [Related]  

  • 14. Why are we using pulse oximetry but not neuromuscular monitoring routinely: the real world scenario?
    de Boer HD; Booij LH
    Anesth Analg; 2014 Mar; 118(3):690. PubMed ID: 24557114
    [No Abstract]   [Full Text] [Related]  

  • 15. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of experiencing 'can't intubate, can't oxygenate'.
    Riley DP
    Anaesth Intensive Care; 2012 Jul; 40(4):722-3. PubMed ID: 22813508
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnesium sulphate effects on sugammadex reversal time - a reply.
    Germano Filho PA
    Anaesthesia; 2015 Dec; 70(12):1457-8. PubMed ID: 26558864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
    Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
    Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.